Clinical Trial Update: Prospective Assessment After Pediatric Cardiac Ablation (PAPCA)

View source ↗

Summary

This entry notes a completed prospective clinical trial from Stanford evaluating outcomes after pediatric cardiac ablation (PAPCA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Cardiovascular Disease
• Heart Disease
• Supraventricular Tachycardia

Snippet

Sponsor: Stanford University | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED